Announcements Trials
Browse Landscape

Phase

Phase 1 13Phase 3 8Phase 1/2 3Phase 2 1

Status

Active not recruiting 6Recruiting 2

Sponsor Class

INDUSTRY 8OTHER 2

Study Type

Interventional 8

Sponsor

Cancer Type

Breast 6Genitourinary 2

Conditions

Breast Neoplasms 4Prostatic Neoplasms 2Locally Advanced (Inoperable) or Metastatic Breast Cancer 2Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Disease Progression 1

Interventions

Carboplatin 315Paclitaxel 303Cisplatin 250Docetaxel 238pembrolizumab 230Gemcitabine 214Pemetrexed 158Capecitabine 147Rituximab 144Bevacizumab 142Dexamethasone 125Fluorouracil 121Cyclophosphamide 102Trastuzumab 100Doxorubicin 96Nivolumab 93Prednisone 92Oxaliplatin 90atezolizumab 75Leucovorin 72durvalumab 69130-nm albumin-bound paclitaxel 68Injections 66Lenalidomide 63Irinotecan 62Bortezomib 56Letrozole 54Topotecan 53Fulvestrant 53Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 3 × INDUSTRY × capivasertib × Clear all
NCT04862663 2026-05-27

CAPItello-292

AstraZeneca

Phase 3 Recruiting
895 enrolled
Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06982521 2026-05-08

ReDiscover-2

Relay Therapeutics, Inc.

Phase 3 Recruiting
540 enrolled
Breast

Breast Neoplasms

NCT04493853 2026-05-05

CAPItello-281

AstraZeneca

Phase 3 Active not recruiting
1,012 enrolled
Genitourinary

Prostatic Neoplasms

NCT04305496 2026-04-30

CAPItello-291

AstraZeneca

Phase 3 Active not recruiting
818 enrolled 19 charts 2 FDA
Breast

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06764186 2026-04-08

CAPItana

AstraZeneca

Phase 3 Active not recruiting
101 enrolled
Breast

Breast Neoplasms

NCT06635447 2026-03-27

CAPItrue

AstraZeneca

Phase 3 Active not recruiting
258 enrolled
Breast

Breast Neoplasms, Disease Progression

NCT03997123 2025-12-22

CAPItello-290

AstraZeneca

Phase 3 Active not recruiting
923 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05348577 2025-01-27

CAPItello280

AstraZeneca

Phase 3 Active not recruiting
1,035 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡